DrFirst Strengths, Domain Expertise, and Key Differentiators
DrFirst offers a comprehensive set of tools and services that optimize the entire medication management process. From the time a patient is interviewed, a prescription is written and a follow up occurs to confirm a patient is adhering to their care instruction, their platform supports each phase of medication management including secure, HIPAA compliant solutions that help providers curb opioid abuse without negatively impacting patient safety and outcomes. DrFirst is offering e-prescribing for controlled substances (EPCS) and is considered the industry standard for providers nationwide.
DrFirst Recent Developments
In October 2023, DrFirst unveiled Fuzion, an innovative enterprise-wide software platform designed to address the escalating financial and staffing pressures confronting hospitals and health systems. Fuzion leverages clinical-grade AI to optimize various clinical workflows, particularly focusing on medication reconciliation and management. This comprehensive platform integrates a diverse array of functionalities aimed at revolutionizing medication-related processes. By alleviating staff burdens and enhancing patient safety and outcomes, Fuzion represents a significant advancement in healthcare technology.
One of Fuzion's key features is its adaptability, allowing healthcare providers to seamlessly incorporate the entire platform or specific components into existing Epic electronic health record (EHR) workflows. The clinical-grade AI serves as a collaborative tool, assisting healthcare professionals in improving the quality of clinical data and introducing unprecedented efficiency into their daily operations. Overall, Fuzion by DrFirst marks a transformative milestone in healthcare technology, promising to enhance patient care while simultaneously addressing the operational challenges faced by healthcare organizations.
In 2019, DrFirst unveiled its new mobile e-prescribing system dubbed iPrescribe. The new system is designed to help providers improve first-fill medication adherence, fight opioid abuse with in-workflow decision support tools, increase prescriber efficiency including working across multiple care provider facilities and EHRs, and drive better quality of care and reduce medication errors via improved data visibility.
DrFirst revealed that its care collaboration platform, Backline, is being used to mobilize and expand healthcare capacity in the midst of the COVID-19 pandemic. Backline enables the delivery of “healthcare without walls” through telehealth capabilities that empower clinicians to provide patient care beyond the traditional confines of a hospital, doctor’s office, clinic, or long-term care facility.
DrFirst Mergers and Acquisitions (M&A) Activities
In April 2024, DrFirst acquired Myndshft Technologies, Inc., a leader in real-time medical benefits and automated prior authorization (PA) solutions. This strategic move strengthens DrFirst’s capabilities in streamlining specialty medication access, particularly for infusions and in-office injectables covered under medical benefits. By integrating Myndshft’s end-to-end SaaS solutions with DrFirst’s platform, the acquisition aims to reduce administrative burdens on healthcare providers, accelerate prior authorization workflows, and enhance the patient experience by expediting access to critical treatments.
On February 1, 2023, DrFirst made headlines with the acquisition of certain assets from Diagnotes, a company based in Indianapolis. This strategic acquisition is poised to empower Backline by DrFirst, the company's flagship platform, with enhanced capabilities aimed at dismantling communication barriers prevalent in healthcare settings across all stages of the patient care continuum. By integrating Diagnotes' assets into its portfolio, DrFirst seeks to fortify Backline's capacity to facilitate seamless communication among healthcare stakeholders, ultimately fostering improved patient outcomes and elevating satisfaction levels for both patients and staff members.
In 2017, DrFirst acquired VisibilityRx for clinical trial recruitment services to life sciences, clinical research organizations, and pharmacies.
In 2016, DrFirst acquired iPrescribe.net, a mobile e-prescribing application. Its standalone E-prescribing solution is used by 250 PM and EHR systems. Also, It has developed a modular EHR for Meaningful Use.
In 2011, DrFirst's acquisition of AdherenceRx enabled it to create its new Patient Innovation division that provides the electronic tools, health coaching, and patient support via phone, email and SMS text that physician practices and health plans need to reduce medical non-adherence.
DrFirst Customers in ARTW Customer Database
Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying DrFirst applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of DrFirst and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified DrFirst Cloud (Blackline, iPrescribe, EPCS Gold, MedHx, PatientAdvisor, Rcopia, SmartStrings, SmartSearch,SmartSig), DrFirst SmartSuite AI, Fuzion by DrFirst customers.
DrFirst Overview
9420 Key West Ave. Suite 230
Rockville, MD, 20850, United States
1 301-231-9510
https://www.drfirst.com/
Ownership: - x
Number of Employees: 500
Functional Markets: Collaboration, CRM, ERP Services and Operations,
Key Verticals: Healthcare,
DrFirst Key Enterprise and Cloud Applications
DrFirst Cloud (Blackline, iPrescribe, EPCS Gold, MedHx, PatientAdvisor, Rcopia, SmartStrings, SmartSearch,SmartSig), DrFirst SmartSuite AI, Fuzion by DrFirst
DrFirst Revenues, $M:
Type/Year | 2023 | 2024 | YoY Growth, % |
---|---|---|---|
Total Revenues, $M | Subscribe | Subscribe | Subscribe |
Enterprise Applications Revenues, $M | Subscribe | Subscribe | Subscribe |
Cloud Applications Revenues, $M | Subscribe | Subscribe | Subscribe |
* Enterprise Applications Revenues = License + Support & Maintenance + SaaS
** All revenue figures are estimates based on public records, Cloud and Non-Cloud business models in Apps Run The World's vendor database, and annual survey results including vendor feedback.
DrFirst Revenue Breakdown By Type, $M:
DrFirst Enterprise Applications Revenues By Functional Markets, $M:
DrFirst Enterprise Applications Revenues By Verticals, $M:
DrFirst Revenues By Region, $M
Region | % of Total Revenues | 2024 Total Revenues, $M | 2024 Enterprise Applications Revenues, $M | 2024 Cloud Applications Revenues, $M |
---|---|---|---|---|
Americas | Subscribe | Subscribe | Subscribe | Subscribe |
EMEA | Subscribe | Subscribe | Subscribe | Subscribe |
APAC | Subscribe | Subscribe | Subscribe | Subscribe |
Total | Subscribe | Subscribe | Subscribe | Subscribe |
DrFirst Direct vs Indirect sales
Type | Direct Sales | Indirect Sales | Total |
---|---|---|---|
Type % | Subscribe | Subscribe | Subscribe |
Revenues, $M | Subscribe | Subscribe | Subscribe |
DrFirst Customers - Breakdown by Geo, Size, Vertical and Product
List of Verified DrFirst Customers
No. of DrFirst Customers: 2000
No. of DrFirst Enterprise Applications Customers: 2000
No. of DrFirst Cloud Customers: x
No. of DrFirst Cloud Subscribers: 350000
DrFirst products are used by over 350,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and 2,000 hospitals in the U.S. and Canada.
Among DrFirst customers are Hugh Chatham Memorial Hospital, ManagementPlus, Berger Health, Cedar Creek Living Center, Knox Community Hospital, Avera Health, Groves Community Hospice, North Canyon Medical Center, North Texas Hand Surgery Associates, Sebasticook Valley Health, Greenway, Crescent City Surgical Center, Summit Healthcare Regional Medical Center, Bogardus Medical Systems, Oakland Southfield Physicians, Huron Valley Physicians Association and many other.
DrFirst Market Opportunities, M&A and Geo Expansions
In January 2023, DrFirst ushered in a significant change as it welcomed its first new CEO in 23 years. This transition marked a pivotal moment for the Rockville-based company, signaling its intention to intensify its focus on the pharmacy market as a strategic avenue for expanding its medication management business. The departure of founder and long-serving CEO James Chen from his operational role in January marked a shift in leadership dynamics within the organization. Under Cameron Deemer's leadership, DrFirst is poised to leverage its expertise and innovative solutions to deepen its penetration into the pharmacy market. With a comprehensive suite of software and mobile products tailored to medical providers, DrFirst remains committed to ensuring optimal medication management and adherence, thereby empowering patients to effectively manage their treatment regimens.
In May 2021, DrFirst closed a $50 million equity investment from Sixth Street Growth, the growth investing platform of Sixth Street, a leading global investment firm. Following Sixth Street’s previous $35 million investment and another $50 million from Goldman Sachs Growth, both in 2020, DrFirst’s investment total over the past year is now $135 million.
DrFirst Risks and Challenges
While DrFirst has grown organically, its ability to scale rapidly may depend on strategic acquisitions, which could challenge its collaborative culture and internal agility.
DrFirst Ecosystem, Partners, Resellers and SI
DrFirst has built a robust partner network, collaborating with EHR vendors, health IT providers, and pharmacies to enhance interoperability and streamline medication workflows. With partnerships spanning over 330 vendors, including ACOM Health, Acumen Physician Solutions, Azalea Health Innovation, Benchmark Systems, Chartlogic, and many more, DrFirst strengthens its market presence by ensuring seamless connectivity across prescribers, pharmacies, and healthcare organizations, ultimately improving medication management and patient outcomes.
Research Methodology
Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.
Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).
For additional information on our methodologies, here's the link:
https://www.appsruntheworld.com/About Ushttps://www.appsruntheworld.com/taxonomy
https://www.appsruntheworld.com/FAQ